Home MarketAlbert David Ltd.

Albert David Ltd. Stock Info: As on 2018-05-24 15:44:37

Nse

362.35

-0.40(-0.11%)
Change%
52 Week Range
275.00
30.00
498.00
12.00
Open362.00
Day's Range344.61 - 380.89
Value Traded (in ₹ Cr.) 0.07

Bse

358.70

-7.30(-1.99%)
Change %
52 Week Range
276.00
15.00
497.00
12.00
Open356.10
Day's Range347.70 - 384.30
Value Traded (in ₹ Cr.) 0.00

Stock Exchange

Category No. Of Shares Share %
ForeignPromoters 0.00 0.00%
IndianPromoters 3,475,514.00 60.90%
Mutual Funds/UTI 900.00 0.02%
FII 0.00 0.00%
Employee 0.00 0.00%
Public 1,659,937.00 29.09%
Government 0.00 0.00%
Others 308,635.00 5.41%
More

Key Statistics

Valuation Measures
Market Cap / Sales Ratio 0.59
Basic EPS (Rs.) 21.09
Cash EPS 34.52
BVPerShare Excl 260.83
Operating Revenue 533.75
PBDITPerShare 50.85
Dividend 5.50
NPPerShare 21.09
Current Ratio 1.91
Quick Ratio 1.31
PriceToBV 1.22
Earnings 0.06
PBDIT Margin 9.52
PBT Margin 6.64
NP Margin 3.95
Return On Assets 4.88
Retention Ratios 0.00
Parameter Mar-17 (₹ Cr.) Yoy%change
Total Income 308.62
Total Expenses 288.38
EBITDA 29.02
PBT 20.25
PAT 12.04
Net Income 12.04
More
Parameter Sep-17 (₹ Cr.) 6M % change
Total Income 149.06
Total Expenses 147.76
EBITDA -2.86
PBT 0.86
PAT 0.04
Net Income 0.00
More
Total Assets
Total Assets
Parameter Mar-17 (₹ Cr.) Yoy%change
Total share capital 5.71
Net worth 148.86
Investments 55.50
Total Liability 246.46
Total debt 31.15
Net block 61.51
Total Assets 246.46
Parameter Sep-17 (₹ Cr.) 6M % change
Total share capital 5.71
Net worth 102.01
Investments 16.50
Total Liability 198.80
Total debt 21.19
Net block 51.38
Total Assets 198.80
Company Curr Price Prev. Close Change% W's Low/High

Aarti Drugs Ltd.

533.05 531.95 0.21
524.95580

Abbott India Ltd.

6671.7 6587.45 1.28
65106890

Ajanta Pharma Ltd.

977.6 987 -0.95
962.351074.5

Alembic Ltd.

48.85 50.8 -3.84
50.254

Alembic Pharmaceuticals Ltd.

420.7 422.3 -0.38
418.5491.2

Alkem Laboratories Ltd.

1957.55 1965.35 -0.4
18882036.65

Alpa Laboratories Ltd.

32.1 32.55 -1.38
31.5534.4
Company Curr Price Prev. Close Change% W's Low/High

Aarey Drugs & Pharmaceuticals Ltd.

47.5 49.05 -3.16
46.351.55

Aarti Drugs Ltd.

530 529.15 0.16
526585

Aayush Food & Herbs Ltd.

47.7 48.1 -0.83
4355

Abbott India Ltd.

6699.95 6593.7 1.61
6465.056872.5

ABL Bio-Technologies Ltd.

0.81 0.78 3.85
0.750.81

Addlife Pharma Ltd.

0.46 0 0
0.460.5

Adinath Bio-Labs Ltd.

0.3 0.31 -3.23
0.30.3
More
Parameter Mar-17(in ₹ Cr.)
Cash from operating activities 19.67
Cash from investing activities -36.25
Cash from financing activities 9.16
Net change in cash -7.16

Stock Held By Mutual Fund Schemes

M Venkatesh appointed MRPL MD

M Venkatesh has been appointed as the Managing Director of Mangalore Refineries and Petrochemicals Limited (MRPL), an order issued by the Personnel Ministry said today. Vekatesh is at present Director (Refineries) in the MRPL, a subsidiary of the Oil and Natural Gas Corporation Limited (ONGC) He has been appointed to the post for a period of five years with effect from the date of his assumption of charge of the post on or after June 1, 2018, or till the date of his superannuation, the order said.

24-05-2018 11:42

TCS expands operations in Florida as part of Transamerica deal

India's largest IT services firm TCS today said it has expanded operations in Florida, US, with over 430 employees joining the company as part of its deal with Transamerica. In January, Tata Consultancy Services (TCS) had signed an over USD 2 billion deal with Transamerica to administer the latter's life insurance, annuity, supplemental health insurance, and workplace voluntary benefits products. It covered managing administration of more than 10 million policies. More than 430 former Transamerica employees now work for TCS at this new St Petersburg facility (in Florida) as part of recruiting and investing in more than 2,200 Transamerica jobs across the US in multiple locations, the Indian software services giant said in a statement. TCS will occupy several floors of Transamerica's building at 570 Carillon Parkway in St Petersburg, as part of a multi-year agreement with Transamerica... The St Petersburg office is a new US business centre for TCS, adding to the over 1,000 employees already serving American businesses throughout the state, it added. TCS said it has invested nearly USD 3 billion in the US over the past three years and has been among the top two IT services job creators in the country. TCS is a leading industry employer in the US, striving to help American companies like Transamerica to digitally transform their business and capitalise on rapidly evolving customer demands, TCS President and Global Head (Banking, Financial Services and Insurance Platforms) Suresh Muthuswami said. We look forward to partnering with St Petersburg's city, state and local organizations to further build upon our business and community impact, he added. The company said it has made tremendous community impact in Florida over past several years.

24-05-2018 11:16

Kotak India Growth Fund Series 4 - Direct Plan: change in investment factsheets for April

Kotak India Growth Fund Series 4 - Direct Plan has announced change in investment factsheets and fund flash for the month ended April 30, 2018. As on Apr 30, 2018, the total size of the Fund was Rs 429.99 crores, compared with Rs 424.96 crores in the last month. The Fund's NAV per unit was Rs 9.89 for Growth, while 52-Week High and Low ranges were Rs 10.35 and Rs 9.51 respectively. The Equity - Diversified fund with Growth plan was launched on Jan 29, 2018 and managed by Fund Managers Harsha Upadhyaya, Devender Singhal. The top five companies based on a percentage of total holdings were ITC Ltd. (35.18 Cr.), HDFC Bank Ltd. (19.44 Cr.), Mahindra & Mahindra Ltd. (19.21 Cr.), Tata Motors Ltd. (17.02 Cr.) and Bata India Ltd. (16.05 Cr.). Kotak India Growth Fund Series 4 - Direct Plan is promoted by Kotak Mahindra Mutual Fund and managed by Kotak Mahindra Asset Management Company Ltd..

24-05-2018 11:00

Kotak India Growth Fund Series 4: change in investment factsheets for April

Kotak India Growth Fund Series 4 has announced change in investment factsheets and fund flash for the month ended April 30, 2018. As on Apr 30, 2018, the total size of the Fund was Rs 429.99 crores, compared with Rs 424.96 crores in the last month. The Fund's NAV per unit was Rs 9.88 for Growth, while 52-Week High and Low ranges were Rs 10.34 and Rs 9.51 respectively. The Equity - Diversified fund with Growth plan was launched on Jan 29, 2018 and managed by Fund Managers Harsha Upadhyaya, Devender Singhal. The top five companies based on a percentage of total holdings were ITC Ltd. (35.18 Cr.), HDFC Bank Ltd. (19.44 Cr.), Mahindra & Mahindra Ltd. (19.21 Cr.), Tata Motors Ltd. (17.02 Cr.) and Bata India Ltd. (16.05 Cr.). Kotak India Growth Fund Series 4 is promoted by Kotak Mahindra Mutual Fund and managed by Kotak Mahindra Asset Management Company Ltd..

24-05-2018 11:00

BLS International to assist Sopra Steria on UK visa renewals

Visa service provider BLS International today said theUnited Kingdom Visas and Immigration (UKVI) has awarded Sopra Steria a new contract to enable visa renewals for those individuals who are already in the UK. BLS International will support Sopra Steria and UKVI, a division of the UK Home Office responsible for deciding who can visit and stay within the UK, by establishing and delivering some of the key add value services under the contract, it said in a release. BLS International claims to handle about 12 million visa applications annually across the globe at present. Meanwhile, shares of the company were trading at Rs 172.55 apiece, up 1 per cent from the previous close at 10:50 hours on BSE.

24-05-2018 10:51

Albert David Ltd - Press Release

Albert David Limited has informed the Exchange regarding a press release dated May 19, 2018, titled Notice of Board Meeting on 29th May, 2018.

19-May-2018 01:01 PM

Albert David Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

We enclose herewith copy of the Notice of Board Meeting to be held on 29th May, 2018, as published in Business Standard (English) and Aajkal (Bengali) today, for your records.

19-May-2018 12:55 PM

Albert David Ltd - Trading Window

Albert David Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

18-May-2018 02:38 PM

Albert David Ltd - Corporate Action-Board to consider Dividend

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a Meeting of Board of Directors of the Company will be held on Tuesday, the 29th May, 2018, inter-alia, to -

1) Consider and approve the Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended 31st March, 2018;

2) Consider and approve Audited Financial Statements of the Company for the financial year ended 31st March, 2018;

3) Consider recommendation of dividend, if any for the financial year 2017-18.

In view of the aforesaid Board Meeting and in terms of the Company's Code of Conduct for Prohibition of Insider Trading, 'Trading Window' for insiders shall remain closed from Friday, Monday, 21st May, 2018 to Thursday, 31st May, 2018 (both days inclusive).

This is for your information and record.

18-May-2018 02:21 PM

Albert David Ltd - Board Meeting-Closure of Trading Window

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a Meeting of Board of Directors of the Company will be held on Tuesday, the 29th May, 2018, inter-alia, to -

1) Consider and approve the Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended 31st March, 2018;

2) Consider and approve Audited Financial Statements of the Company for the financial year ended 31st March, 2018;

3) Consider recommendation of dividend, if any for the financial year 2017-18.

In view of the aforesaid Board Meeting and in terms of the Company's Code of Conduct for Prohibition of Insider Trading, 'Trading Window' for insiders shall remain closed from Friday, Monday, 21st May, 2018 to Thursday, 31st May, 2018 (both days inclusive).

This is for your information and record.

18-May-2018 02:20 PM

Albert David Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

We enclose herewith copy of the Notice of Board Meeting to be held on 29th May, 2018, as published in Business Standard (English) and Aajkal (Bengali) today, for your records.

19-May-2018 12:55 PM

Albert David Ltd - Corporate Action-Board to consider Dividend

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a Meeting of Board of Directors of the Company will be held on Tuesday, the 29th May, 2018, inter-alia, to -

1) Consider and approve the Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended 31st March, 2018;

2) Consider and approve Audited Financial Statements of the Company for the financial year ended 31st March, 2018;

3) Consider recommendation of dividend, if any for the financial year 2017-18.

In view of the aforesaid Board Meeting and in terms of the Company's Code of Conduct for Prohibition of Insider Trading, 'Trading Window' for insiders shall remain closed from Friday, Monday, 21st May, 2018 to Thursday, 31st May, 2018 (both days inclusive).

This is for your information and record.

18-May-2018 02:21 PM

Albert David Ltd - Board Meeting-Closure of Trading Window

Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that a Meeting of Board of Directors of the Company will be held on Tuesday, the 29th May, 2018, inter-alia, to -

1) Consider and approve the Audited Financial Results of the Company for the Fourth Quarter and Financial Year ended 31st March, 2018;

2) Consider and approve Audited Financial Statements of the Company for the financial year ended 31st March, 2018;

3) Consider recommendation of dividend, if any for the financial year 2017-18.

In view of the aforesaid Board Meeting and in terms of the Company's Code of Conduct for Prohibition of Insider Trading, 'Trading Window' for insiders shall remain closed from Friday, Monday, 21st May, 2018 to Thursday, 31st May, 2018 (both days inclusive).

This is for your information and record.

18-May-2018 02:20 PM

Corporate Details

About Management

The company is engaged in the manufacture of bulk drugs. The company at present manufactures herbal drugs and hypodermic disposable syringes plans to launch the production of broad spectrum antibiotics Ciprofloxacin both in tablet and injection form. The Commonwealth of Independent States states that "For setting up a Joint Venture project for the manufacture of bulk drugs, the company is also tapping on expansion & diversification of its three Units at Calcutta, Ghaziabad and Mandideep in U.P. and proposes to send Rs.30 crores in the next 3 years on this expansion programme. The company has exported anti-biotics worth of Rs.3 crores to Srilanka, Nigeria and few European countries. 2005 - Albert David Limited has entered into an agreement with Japanese chemicals company Ajinomoto Co Inc. Ajinomoto, a leading global manufacturer of amino acids, will provide technical knowhow for developing amino acid based products and will also give Albert David the rights to sell Ajinomoto's products in India. - The company has recommended a dividend at the rate of 20% per ordinary shares of Rs 10/- each for the financial year ended. 2006 - The company has recommended dividend at the rate of 25% per ordinary shares of Rs 10/- each for the financial year ended. 2007 - The company has recommends for payment of dividend @ 30% on Equity Shares of Rs 10/- each. 2008 - The company appointed Mr. Arun Kumar Kohari, Chairman, as also Managing Director. 2009 - The company has recommended for payment of dividend of Rs 3.50 per equity share of Rs 10/- each on 5707162 Equity Shares. 2010 - The company has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each on 5707162 Equity Shares. 2011 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2012 - The company has recommended dividend of Rs. 4.50 per equity shares of Rs. 10/- each for the financial year ended. 2013 -Albert David Ltd has recommended for payment of dividend of Rs. 4.50 per equity share of Rs. 10/- each. 2014 -Albert David Ltd has appointed Mr. Arindam Sarkar as Additional Director of the Company. -Albert David Ltd have recommended dividend of Rs. 5.00 per equity share of Rs. 10/- each.

Registered Office

D - Block, 3rd Floor, Gillander House, Netaji Subhas Road,

033-22302330,22628436,22628456-8492,      033-22258714,

adidavid@dataone.in

http://www.albertdavidindia.com

Registrar Details

Maheshwari Datamatics (P) Ltd.